Abstract:Objective: To explore more efficient treatments for chronic obstructive pulmonary disease (COPD), effective-component compatibility of Bufei Yishen formula III (ECC-BYF III) and electroacupuncture were tested on rats with COPD, and silent information regulator transcript-1 (SIRT1)/nuclear factor-kappaB (NF-κB) signaling was further investigated to interpret the therapy. Methods: In total, 70 rats were randomly divided into control (Control), model (Model), aminophylline (APL), ECC-BYF III, electroacupuncture (EA), ECC-BYF III+EA, and sham electroacupuncture (SA) groups. Cigarette smoke exposure combined with repeated bacterial infections was used to establish COPD models in 1-12 weeks. From 13 to 20 weeks, the ECC-BYF III and APL groups received corresponding drugs; the EA group received electroacupuncture therapy, wherein Dazhui (GV 14), Feishu (BL 13), and Shenshu (BL 23) points were selected; the ECC-BYF III+EA group received ECC-BYF III intragastrically combined with electroacupuncture; and the SA group received simulated electroacupuncture (nonacupoint). Pulmonary function, pulmonary histopathology, the expressions of SIRT1/NF-κB signaling, and inflammation-related mRNA and protein were detected. Results: Significant deterioration was observed in pulmonary function and pulmonary histopathology in rats with COPD (P < 0.01), and inflammatory state was illustrated by increased levels of interleukin- (IL-) 6 and tumor necrosis factor alpha (TNF-α) and decreased levels of IL-10 (P < 0.01). After the intervention of APL, ECC-BYF III, EA, and ECC-BYF III+EA, both pulmonary function and pulmonary histopathology were improved (P < 0.05 and P < 0.01), whereas the levels of IL-6 and TNF-α were decreased and IL-10 was increased (P < 0.05 and P < 0.01). Additionally, the mRNA expressions of IL-6, TNF-α, NF-κB, and acetylated NF-κBp65 (Ac-NF-κB) were noted to decrease, and SIRT1 and IL-10 were increased (P < 0.05 and P < 0.01); the protein expression of SIRT1 was upregulated, and NF-κBp65 and Ac-NF-κB were downregulated (P < 0.05 and P < 0.01). The effect of ECC-BYF III+EA was better in terms of improving pulmonary function and alleviating inflammation than that of the other treatment groups (P < 0.01 and P < 0.05). Conclusions: ECC-BYF III, electroacupuncture, and their combination can suppress inflammation, among which the combination therapy has been proven to be the most effective treatment, and the mechanism may be involved in activating SIRT1/NF-κB signaling.

Baicalin ameliorates cigarette smoke-induced airway inflammation in rats by modulating HDAC2/NF-B/PAI-1 signalling

Baicalin ameliorates cigarette smoke-induced airway inflammation in rats by modulating HDAC2/NF-κB/PAI-1 signalling

Baicalin is anti-inflammatory in cigarette smoke-induced inflammatory models in vivo and in vitro: A possible role for HDAC2 activity

Baicalin Exerts Anti-Airway Inflammation and Anti-Remodelling Effects in Severe Stage Rat Model of Chronic Obstructive Pulmonary Disease

Scutellaria Baicalensis Attenuates Airway Remodeling Via Pi3k/Akt/Nf-Kappa B Pathway In Cigarette Smoke Mediated- Copd Rats Model

Baicalin Inhibits Inflammation in Rats with Chronic Obstructive Pulmonary Disease by the TLR2/MYD88/NF-κBp65 Signaling Pathway

Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF- κ B Signaling

Baicalin attenuates inflammation by inhibiting NF-κB activation in cigarette smoke induced inflammatory models

WNT/β-catenin Signaling Regulates Cigarette Smoke-Induced Airway Inflammation Via the PPARδ/p38 Pathway

Cigarette Smoke Enhances Beta-Defensin 2 Expression in Rat Airways Via Nuclear Factor-Kappa B Activation

Bu-Shen-Fang-Chuan formula attenuates cigarette smoke-induced inflammation by modulating the PI3K/Akt-Nrf2 and NF-κB signalling pathways

Baicalin Attenuates Inflammation in Mice with OVA-induced Asthma by Inhibiting NF-κB and Suppressing CCR7/CCL19/CCL21.

Effects of Baicalin on Airway Remodeling in Asthmatic Mice

Baicalin Inhibits Lipopolysaccharide-Induced Inflammation Through Signaling NF-κB Pathway in HBE16 Airway Epithelial Cells

(−)-Epicatechin Ameliorates Cigarette Smoke-Induced Lung Inflammation Via Inhibiting ROS/NLRP3 Inflammasome Pathway in Rats with COPD

Chinese Medicine Shenqibufei Attenuates Chronic Obstructive Pulmonary Disease

Up-regulation of PPAR- Involved in the Therapeutic Effect of Icariin on Cigarette Smoke-Induced Inflammation

Baicalin Inhibits Airway Smooth Muscle Cells Proliferation Through the RAS Signaling Pathway in Murine Asthmatic Airway Remodeling Model

Sodium Butyrate (SB) Ameliorated Inflammation of COPD Induced by Cigarette Smoke Through Activating the GPR43 to Inhibit NF-κB/MAPKs Signaling Pathways.

Protective Effects of Schisandrin B on Cigarette Smoke-Induced Airway Injury in Mice Through Nrf2 Pathway.

Baicalin relieves complement alternative pathway activation-induced lung inflammation through inhibition of NF-κB pathway